Showing results (501-510 of 977) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|May 29, 2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.NPJ Breast Cancer|May 27, 2021
How can artificial intelligence models assist PD-L1 expression scoring in breast cancer: results of multi-institutional ring studiesXinran Wang, Liang Wang, Hong Bu, et al.NPJ Breast Cancer|December 20, 2022
Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapiesJason A Mouabbi, Akshara Singareeka Raghavendra, Roland L Bassett, et al.NPJ Breast Cancer|June 27, 2017
Moonshots and metastatic disease: the need for a multi-faceted approach when studying atypical responsesKristine De La Torre, Elly Cohen, Anne Loeser, et al.NPJ Breast Cancer|June 27, 2017
Dramatic response of metaplastic breast cancer to chemo-immunotherapySylvia AdamsNPJ Breast Cancer|June 27, 2017
The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screeningNehmat Houssami, Kylie HunterNPJ Breast Cancer|June 27, 2017
Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal womenCaitlin Mason, Lei Wang, Catherine Duggan, et al.NPJ Breast Cancer|February 17, 2022
Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trialRomualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, et al.NPJ Breast Cancer|February 17, 2022
Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancerJung Hwan Ji, Soong June Bae, Kyungsoo Kim, et al.NPJ Breast Cancer|February 19, 2022
Immunotherapy for early triple negative breast cancer: research agenda for the next decadePaolo Tarantino, Chiara Corti, Peter Schmid, et al.Pageof 98